Projects per year
Search results
-
Finished
Effects of Tamoxifen on the Mutant Allele Burden and Disease Course in Patients with Myeloproliferative Neoplasms
Craddock, C. (Principal Investigator), Siddique, S. (Co-Investigator) & Jackson, A. (Co-Investigator)
1/12/15 → 31/12/21
Project: Research
-
Risk-stratified sequential treatment of de-novo post-transplant lymphoproliferative disorder (PTLD) with Ibrutinib and Rituximab (IR) and IR-CHOP
Craddock, C. (Co-Investigator), Jackson, A. (Principal Investigator) & Siddique, S. (Co-Investigator)
BLOODWISE, Janssen-Cilag Limited
1/12/15 → 31/12/23
Project: Research
-
PHAZAR/RuxAza - A phase Ib study to assess the safety and tolerability of oral Ruxolitinib in combination with 5 azacitidine in patients with accelerated phase MPNs, MDS or AML after MPNs
Siddique, S. (Co-Investigator), Fox, S. (Co-Investigator), Fenwick, N. (Co-Investigator) & Jackson, A. (Principal Investigator)
CELGENE INTERNATIONAL SARL, NOVARTIS PHARMACEUTICALS UK LTD, BLOODWISE
1/04/14 → 31/12/24
Project: Research
-
TIER - APhase I/II Study of Thiotepa, Ifosphamide, Etoposide & Rituximab for the treatment of relapsed & refractory primary central nervous system lymphoma
Siddique, S. (Co-Investigator) & Jackson, A. (Principal Investigator)
15/01/14 → 1/06/21
Project: Research